In the preceding three months, 4 analysts have released ratings for Mirion Technologies (NYSE:MIR), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 1 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 2 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $29.25, along with a high estimate of $30.00 and a low estimate of $29.00. Highlighting a 10.47% decrease, the current average has fallen from the previous average price target of $32.67.

An in-depth analysis of recent analyst actions unveils how financial experts perceive Mirion Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Tomohiko Sano | JP Morgan | Lowers | Overweight | $30.00 | $33.00 |
| Andrew Kaplowitz | Citigroup | Lowers | Buy | $29.00 | $32.00 |
| Joe Ritchie | Goldman Sachs | Lowers | Buy | $29.00 | $33.00 |
| Christopher Snyder | Morgan Stanley | Announces | Equal-Weight | $29.00 | - |
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Mirion Technologies's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Mirion Technologies analyst ratings.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Positive Revenue Trend: Examining Mirion Technologies's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.08% as of 31 December, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Mirion Technologies's net margin is impressive, surpassing industry averages. With a net margin of 6.24%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Mirion Technologies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.93% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Mirion Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.49% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.66, Mirion Technologies faces challenges in effectively managing its debt levels, indicating potential financial strain.
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.